The global market for Neurotherapy was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

Neurotherapy, also known as neurofeedback or EEG biofeedback, is a therapeutic approach that utilizes real-time monitoring of brainwave patterns to provide feedback and promote self-regulation of brain activity. It involves the use of specialized equipment to record electrical signals from the brain, which are then processed and presented visually or audibly to the individual receiving therapy. Neurotherapy aims to train and enhance specific brainwave patterns associated with improved cognitive function, emotional regulation, and overall well-being.

North American market for Neurotherapy is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Neurotherapy is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global manufacturers of Neurotherapy include Medtronic, Boston Scientific Corporation, Abbott, Nexalin Technology, Alpha-Stim, Neuro-Fitness, LivaNova, Beijing Pins Medical, SceneRay, RISHENA, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Neurotherapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Neurotherapy.

The Neurotherapy market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Neurotherapy market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Neurotherapy manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Neurotherapy Market Report

Report Metric	Details
Report Name	Neurotherapy Market
Segment by Type	Internal Treatment External Treatment
Segment by Application	Parkinson's Disease Epilepsy Migraine Depression Others
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Medtronic, Boston Scientific Corporation, Abbott, Nexalin Technology, Alpha-Stim, Neuro-Fitness, LivaNova, Beijing Pins Medical, SceneRay, RISHENA, Znion HK
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Neurotherapy manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Neurotherapy in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Neurotherapy Market report?

Ans: The main players in the Neurotherapy Market are Medtronic, Boston Scientific Corporation, Abbott, Nexalin Technology, Alpha-Stim, Neuro-Fitness, LivaNova, Beijing Pins Medical, SceneRay, RISHENA, Znion HK

What are the Application segmentation covered in the Neurotherapy Market report?

Ans: The Applications covered in the Neurotherapy Market report are Parkinson's Disease, Epilepsy, Migraine, Depression, Others

What are the Type segmentation covered in the Neurotherapy Market report?

Ans: The Types covered in the Neurotherapy Market report are Internal Treatment, External Treatment

1 Neurotherapy Market Overview

1.1 Product Definition

1.2 Neurotherapy by Type

1.2.1 Global Neurotherapy Market Value Comparison by Type (2024 VS 2031)

1.2.2 Internal Treatment

1.2.3 External Treatment

1.3 Neurotherapy by Application

1.3.1 Global Neurotherapy Market Value by Application (2024 VS 2031)

1.3.2 Parkinson's Disease

1.3.3 Epilepsy

1.3.4 Migraine

1.3.5 Depression

1.3.6 Others

1.4 Global Neurotherapy Market Size Estimates and Forecasts

1.4.1 Global Neurotherapy Revenue 2020-2031

1.4.2 Global Neurotherapy Sales 2020-2031

1.4.3 Global Neurotherapy Market Average Price (2020-2031)

1.5 Assumptions and Limitations

2 Neurotherapy Market Competition by Manufacturers

2.1 Global Neurotherapy Sales Market Share by Manufacturers (2020-2025)

2.2 Global Neurotherapy Revenue Market Share by Manufacturers (2020-2025)

2.3 Global Neurotherapy Average Price by Manufacturers (2020-2025)

2.4 Global Key Players of Neurotherapy, Industry Ranking, 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Neurotherapy, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Neurotherapy, Product Type & Application

2.7 Global Key Manufacturers of Neurotherapy, Date of Enter into This Industry

2.8 Global Neurotherapy Market Competitive Situation and Trends

2.8.1 Global Neurotherapy Market Concentration Rate

2.8.2 The Global 5 and 10 Largest Neurotherapy Players Market Share by Revenue

2.8.3 Global Neurotherapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global Neurotherapy Market Scenario by Region

3.1 Global Neurotherapy Market Size by Region: 2020 Versus 2024 Versus 2031

3.2 Global Neurotherapy Sales by Region: 2020-2031

3.2.1 Global Neurotherapy Sales by Region: 2020-2025

3.2.2 Global Neurotherapy Sales by Region: 2026-2031

3.3 Global Neurotherapy Revenue by Region: 2020-2031

3.3.1 Global Neurotherapy Revenue by Region: 2020-2025

3.3.2 Global Neurotherapy Revenue by Region: 2026-2031

3.4 North America Neurotherapy Market Facts & Figures by Country

3.4.1 North America Neurotherapy Market Size by Country: 2020 VS 2024 VS 2031

3.4.2 North America Neurotherapy Sales by Country (2020-2031)

3.4.3 North America Neurotherapy Revenue by Country (2020-2031)

3.4.4 United States

3.4.5 Canada

3.5 Europe Neurotherapy Market Facts & Figures by Country

3.5.1 Europe Neurotherapy Market Size by Country: 2020 VS 2024 VS 2031

3.5.2 Europe Neurotherapy Sales by Country (2020-2031)

3.5.3 Europe Neurotherapy Revenue by Country (2020-2031)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Neurotherapy Market Facts & Figures by Region

3.6.1 Asia Pacific Neurotherapy Market Size by Region: 2020 VS 2024 VS 2031

3.6.2 Asia Pacific Neurotherapy Sales by Region (2020-2031)

3.6.3 Asia Pacific Neurotherapy Revenue by Region (2020-2031)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Southeast Asia

3.7 Latin America Neurotherapy Market Facts & Figures by Country

3.7.1 Latin America Neurotherapy Market Size by Country: 2020 VS 2024 VS 2031

3.7.2 Latin America Neurotherapy Sales by Country (2020-2031)

3.7.3 Latin America Neurotherapy Revenue by Country (2020-2031)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Neurotherapy Market Facts & Figures by Country

3.8.1 Middle East and Africa Neurotherapy Market Size by Country: 2020 VS 2024 VS 2031

3.8.2 Middle East and Africa Neurotherapy Sales by Country (2020-2031)

3.8.3 Middle East and Africa Neurotherapy Revenue by Country (2020-2031)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global Neurotherapy Sales by Type (2020-2031)

4.1.1 Global Neurotherapy Sales by Type (2020-2025)

4.1.2 Global Neurotherapy Sales by Type (2026-2031)

4.1.3 Global Neurotherapy Sales Market Share by Type (2020-2031)

4.2 Global Neurotherapy Revenue by Type (2020-2031)

4.2.1 Global Neurotherapy Revenue by Type (2020-2025)

4.2.2 Global Neurotherapy Revenue by Type (2026-2031)

4.2.3 Global Neurotherapy Revenue Market Share by Type (2020-2031)

4.3 Global Neurotherapy Price by Type (2020-2031)

5 Segment by Application

5.1 Global Neurotherapy Sales by Application (2020-2031)

5.1.1 Global Neurotherapy Sales by Application (2020-2025)

5.1.2 Global Neurotherapy Sales by Application (2026-2031)

5.1.3 Global Neurotherapy Sales Market Share by Application (2020-2031)

5.2 Global Neurotherapy Revenue by Application (2020-2031)

5.2.1 Global Neurotherapy Revenue by Application (2020-2025)

5.2.2 Global Neurotherapy Revenue by Application (2026-2031)

5.2.3 Global Neurotherapy Revenue Market Share by Application (2020-2031)

5.3 Global Neurotherapy Price by Application (2020-2031)

6 Key Companies Profiled

6.1 Medtronic

6.1.1 Medtronic Company Information

6.1.2 Medtronic Description and Business Overview

6.1.3 Medtronic Neurotherapy Sales, Revenue and Gross Margin (2020-2025)

6.1.4 Medtronic Neurotherapy Product Portfolio

6.1.5 Medtronic Recent Developments/Updates

6.2 Boston Scientific Corporation

6.2.1 Boston Scientific Corporation Company Information

6.2.2 Boston Scientific Corporation Description and Business Overview

6.2.3 Boston Scientific Corporation Neurotherapy Sales, Revenue and Gross Margin (2020-2025)

6.2.4 Boston Scientific Corporation Neurotherapy Product Portfolio

6.2.5 Boston Scientific Corporation Recent Developments/Updates

6.3 Abbott

6.3.1 Abbott Company Information

6.3.2 Abbott Description and Business Overview

6.3.3 Abbott Neurotherapy Sales, Revenue and Gross Margin (2020-2025)

6.3.4 Abbott Neurotherapy Product Portfolio

6.3.5 Abbott Recent Developments/Updates

6.4 Nexalin Technology

6.4.1 Nexalin Technology Company Information

6.4.2 Nexalin Technology Description and Business Overview

6.4.3 Nexalin Technology Neurotherapy Sales, Revenue and Gross Margin (2020-2025)

6.4.4 Nexalin Technology Neurotherapy Product Portfolio

6.4.5 Nexalin Technology Recent Developments/Updates

6.5 Alpha-Stim

6.5.1 Alpha-Stim Company Information

6.5.2 Alpha-Stim Description and Business Overview

6.5.3 Alpha-Stim Neurotherapy Sales, Revenue and Gross Margin (2020-2025)

6.5.4 Alpha-Stim Neurotherapy Product Portfolio

6.5.5 Alpha-Stim Recent Developments/Updates

6.6 Neuro-Fitness

6.6.1 Neuro-Fitness Company Information

6.6.2 Neuro-Fitness Description and Business Overview

6.6.3 Neuro-Fitness Neurotherapy Sales, Revenue and Gross Margin (2020-2025)

6.6.4 Neuro-Fitness Neurotherapy Product Portfolio

6.6.5 Neuro-Fitness Recent Developments/Updates

6.7 LivaNova

6.7.1 LivaNova Company Information

6.7.2 LivaNova Description and Business Overview

6.7.3 LivaNova Neurotherapy Sales, Revenue and Gross Margin (2020-2025)

6.7.4 LivaNova Neurotherapy Product Portfolio

6.7.5 LivaNova Recent Developments/Updates

6.8 Beijing Pins Medical

6.8.1 Beijing Pins Medical Company Information

6.8.2 Beijing Pins Medical Description and Business Overview

6.8.3 Beijing Pins Medical Neurotherapy Sales, Revenue and Gross Margin (2020-2025)

6.8.4 Beijing Pins Medical Neurotherapy Product Portfolio

6.8.5 Beijing Pins Medical Recent Developments/Updates

6.9 SceneRay

6.9.1 SceneRay Company Information

6.9.2 SceneRay Description and Business Overview

6.9.3 SceneRay Neurotherapy Sales, Revenue and Gross Margin (2020-2025)

6.9.4 SceneRay Neurotherapy Product Portfolio

6.9.5 SceneRay Recent Developments/Updates

6.10 RISHENA

6.10.1 RISHENA Company Information

6.10.2 RISHENA Description and Business Overview

6.10.3 RISHENA Neurotherapy Sales, Revenue and Gross Margin (2020-2025)

6.10.4 RISHENA Neurotherapy Product Portfolio

6.10.5 RISHENA Recent Developments/Updates

6.11 Znion HK

6.11.1 Znion HK Company Information

6.11.2 Znion HK Description and Business Overview

6.11.3 Znion HK Neurotherapy Sales, Revenue and Gross Margin (2020-2025)

6.11.4 Znion HK Neurotherapy Product Portfolio

6.11.5 Znion HK Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Neurotherapy Industry Chain Analysis

7.2 Neurotherapy Raw Material Supply Analysis

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Neurotherapy Production Mode & Process Analysis

7.4 Neurotherapy Sales and Marketing

7.4.1 Neurotherapy Sales Channels

7.4.2 Neurotherapy Distributors

7.5 Neurotherapy Customer Analysis

8 Neurotherapy Market Dynamics

8.1 Neurotherapy Industry Trends

8.2 Neurotherapy Market Drivers

8.3 Neurotherapy Market Challenges

8.4 Neurotherapy Market Restraints

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

List of Tables

Table 1. Global Neurotherapy Market Value Comparison by Type (2024 VS 2031) & (US$ Million)

Table 2. Global Neurotherapy Market Value by Application (2024 VS 2031) & (US$ Million)

Table 3. Global Neurotherapy Market Competitive Situation by Manufacturers in 2024

Table 4. Global Neurotherapy Sales (K Units) of Key Manufacturers (2020-2025)

Table 5. Global Neurotherapy Sales Market Share by Manufacturers (2020-2025)

Table 6. Global Neurotherapy Revenue (US$ Million) by Manufacturers (2020-2025)

Table 7. Global Neurotherapy Revenue Share by Manufacturers (2020-2025)

Table 8. Global Market Neurotherapy Average Price (US$/Unit) of Key Manufacturers (2020-2025)

Table 9. Global Key Players of Neurotherapy, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Neurotherapy, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Neurotherapy, Product Type & Application

Table 12. Global Key Manufacturers of Neurotherapy, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Neurotherapy by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Neurotherapy as of 2024)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Neurotherapy Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 17. Global Neurotherapy Sales by Region (2020-2025) & (K Units)

Table 18. Global Neurotherapy Sales Market Share by Region (2020-2025)

Table 19. Global Neurotherapy Sales by Region (2026-2031) & (K Units)

Table 20. Global Neurotherapy Sales Market Share by Region (2026-2031)

Table 21. Global Neurotherapy Revenue by Region (2020-2025) & (US$ Million)

Table 22. Global Neurotherapy Revenue Market Share by Region (2020-2025)

Table 23. Global Neurotherapy Revenue by Region (2026-2031) & (US$ Million)

Table 24. Global Neurotherapy Revenue Market Share by Region (2026-2031)

Table 25. North America Neurotherapy Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 26. North America Neurotherapy Sales by Country (2020-2025) & (K Units)

Table 27. North America Neurotherapy Sales by Country (2026-2031) & (K Units)

Table 28. North America Neurotherapy Revenue by Country (2020-2025) & (US$ Million)

Table 29. North America Neurotherapy Revenue by Country (2026-2031) & (US$ Million)

Table 30. Europe Neurotherapy Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 31. Europe Neurotherapy Sales by Country (2020-2025) & (K Units)

Table 32. Europe Neurotherapy Sales by Country (2026-2031) & (K Units)

Table 33. Europe Neurotherapy Revenue by Country (2020-2025) & (US$ Million)

Table 34. Europe Neurotherapy Revenue by Country (2026-2031) & (US$ Million)

Table 35. Asia Pacific Neurotherapy Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 36. Asia Pacific Neurotherapy Sales by Region (2020-2025) & (K Units)

Table 37. Asia Pacific Neurotherapy Sales by Region (2026-2031) & (K Units)

Table 38. Asia Pacific Neurotherapy Revenue by Region (2020-2025) & (US$ Million)

Table 39. Asia Pacific Neurotherapy Revenue by Region (2026-2031) & (US$ Million)

Table 40. Latin America Neurotherapy Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 41. Latin America Neurotherapy Sales by Country (2020-2025) & (K Units)

Table 42. Latin America Neurotherapy Sales by Country (2026-2031) & (K Units)

Table 43. Latin America Neurotherapy Revenue by Country (2020-2025) & (US$ Million)

Table 44. Latin America Neurotherapy Revenue by Country (2026-2031) & (US$ Million)

Table 45. Middle East and Africa Neurotherapy Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 46. Middle East and Africa Neurotherapy Sales by Country (2020-2025) & (K Units)

Table 47. Middle East and Africa Neurotherapy Sales by Country (2026-2031) & (K Units)

Table 48. Middle East and Africa Neurotherapy Revenue by Country (2020-2025) & (US$ Million)

Table 49. Middle East and Africa Neurotherapy Revenue by Country (2026-2031) & (US$ Million)

Table 50. Global Neurotherapy Sales (K Units) by Type (2020-2025)

Table 51. Global Neurotherapy Sales (K Units) by Type (2026-2031)

Table 52. Global Neurotherapy Sales Market Share by Type (2020-2025)

Table 53. Global Neurotherapy Sales Market Share by Type (2026-2031)

Table 54. Global Neurotherapy Revenue (US$ Million) by Type (2020-2025)

Table 55. Global Neurotherapy Revenue (US$ Million) by Type (2026-2031)

Table 56. Global Neurotherapy Revenue Market Share by Type (2020-2025)

Table 57. Global Neurotherapy Revenue Market Share by Type (2026-2031)

Table 58. Global Neurotherapy Price (US$/Unit) by Type (2020-2025)

Table 59. Global Neurotherapy Price (US$/Unit) by Type (2026-2031)

Table 60. Global Neurotherapy Sales (K Units) by Application (2020-2025)

Table 61. Global Neurotherapy Sales (K Units) by Application (2026-2031)

Table 62. Global Neurotherapy Sales Market Share by Application (2020-2025)

Table 63. Global Neurotherapy Sales Market Share by Application (2026-2031)

Table 64. Global Neurotherapy Revenue (US$ Million) by Application (2020-2025)

Table 65. Global Neurotherapy Revenue (US$ Million) by Application (2026-2031)

Table 66. Global Neurotherapy Revenue Market Share by Application (2020-2025)

Table 67. Global Neurotherapy Revenue Market Share by Application (2026-2031)

Table 68. Global Neurotherapy Price (US$/Unit) by Application (2020-2025)

Table 69. Global Neurotherapy Price (US$/Unit) by Application (2026-2031)

Table 70. Medtronic Company Information

Table 71. Medtronic Description and Business Overview

Table 72. Medtronic Neurotherapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 73. Medtronic Neurotherapy Product

Table 74. Medtronic Recent Developments/Updates

Table 75. Boston Scientific Corporation Company Information

Table 76. Boston Scientific Corporation Description and Business Overview

Table 77. Boston Scientific Corporation Neurotherapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 78. Boston Scientific Corporation Neurotherapy Product

Table 79. Boston Scientific Corporation Recent Developments/Updates

Table 80. Abbott Company Information

Table 81. Abbott Description and Business Overview

Table 82. Abbott Neurotherapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 83. Abbott Neurotherapy Product

Table 84. Abbott Recent Developments/Updates

Table 85. Nexalin Technology Company Information

Table 86. Nexalin Technology Description and Business Overview

Table 87. Nexalin Technology Neurotherapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 88. Nexalin Technology Neurotherapy Product

Table 89. Nexalin Technology Recent Developments/Updates

Table 90. Alpha-Stim Company Information

Table 91. Alpha-Stim Description and Business Overview

Table 92. Alpha-Stim Neurotherapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 93. Alpha-Stim Neurotherapy Product

Table 94. Alpha-Stim Recent Developments/Updates

Table 95. Neuro-Fitness Company Information

Table 96. Neuro-Fitness Description and Business Overview

Table 97. Neuro-Fitness Neurotherapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 98. Neuro-Fitness Neurotherapy Product

Table 99. Neuro-Fitness Recent Developments/Updates

Table 100. LivaNova Company Information

Table 101. LivaNova Description and Business Overview

Table 102. LivaNova Neurotherapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 103. LivaNova Neurotherapy Product

Table 104. LivaNova Recent Developments/Updates

Table 105. Beijing Pins Medical Company Information

Table 106. Beijing Pins Medical Description and Business Overview

Table 107. Beijing Pins Medical Neurotherapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 108. Beijing Pins Medical Neurotherapy Product

Table 109. Beijing Pins Medical Recent Developments/Updates

Table 110. SceneRay Company Information

Table 111. SceneRay Description and Business Overview

Table 112. SceneRay Neurotherapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 113. SceneRay Neurotherapy Product

Table 114. SceneRay Recent Developments/Updates

Table 115. RISHENA Company Information

Table 116. RISHENA Description and Business Overview

Table 117. RISHENA Neurotherapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 118. RISHENA Neurotherapy Product

Table 119. RISHENA Recent Developments/Updates

Table 120. Znion HK Company Information

Table 121. Znion HK Description and Business Overview

Table 122. Znion HK Neurotherapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 123. Znion HK Neurotherapy Product

Table 124. Znion HK Recent Developments/Updates

Table 125. Key Raw Materials Lists

Table 126. Raw Materials Key Suppliers Lists

Table 127. Neurotherapy Distributors List

Table 128. Neurotherapy Customers List

Table 129. Neurotherapy Market Trends

Table 130. Neurotherapy Market Drivers

Table 131. Neurotherapy Market Challenges

Table 132. Neurotherapy Market Restraints

Table 133. Research Programs/Design for This Report

Table 134. Key Data Information from Secondary Sources

Table 135. Key Data Information from Primary Sources

Table 136. Authors List of This Report

List of Figures

Figure 1. Product Picture of Neurotherapy

Figure 2. Global Neurotherapy Market Value Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Neurotherapy Market Share by Type: 2024 & 2031

Figure 4. Internal Treatment Product Picture

Figure 5. External Treatment Product Picture

Figure 6. Global Neurotherapy Market Value by Application (2020-2031) & (US$ Million)

Figure 7. Global Neurotherapy Market Share by Application: 2024 & 2031

Figure 8. Parkinson's Disease

Figure 9. Epilepsy

Figure 10. Migraine

Figure 11. Depression

Figure 12. Others

Figure 13. Global Neurotherapy Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 14. Global Neurotherapy Market Size (2020-2031) & (US$ Million)

Figure 15. Global Neurotherapy Sales (2020-2031) & (K Units)

Figure 16. Global Neurotherapy Average Price (US$/Unit) & (2020-2031)

Figure 17. Neurotherapy Report Years Considered

Figure 18. Neurotherapy Sales Share by Manufacturers in 2024

Figure 19. Global Neurotherapy Revenue Share by Manufacturers in 2024

Figure 20. Global 5 and 10 Largest Neurotherapy Players: Market Share by Revenue in Neurotherapy in 2024

Figure 21. Neurotherapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 22. Global Neurotherapy Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Figure 23. North America Neurotherapy Sales Market Share by Country (2020-2031)

Figure 24. North America Neurotherapy Revenue Market Share by Country (2020-2031)

Figure 25. United States Neurotherapy Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 26. Canada Neurotherapy Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 27. Europe Neurotherapy Sales Market Share by Country (2020-2031)

Figure 28. Europe Neurotherapy Revenue Market Share by Country (2020-2031)

Figure 29. Germany Neurotherapy Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 30. France Neurotherapy Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 31. U.K. Neurotherapy Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 32. Italy Neurotherapy Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 33. Russia Neurotherapy Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 34. Asia Pacific Neurotherapy Sales Market Share by Region (2020-2031)

Figure 35. Asia Pacific Neurotherapy Revenue Market Share by Region (2020-2031)

Figure 36. China Neurotherapy Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 37. Japan Neurotherapy Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 38. South Korea Neurotherapy Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 39. India Neurotherapy Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 40. Australia Neurotherapy Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 41. China Taiwan Neurotherapy Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 42. Southeast Asia Neurotherapy Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 43. Latin America Neurotherapy Sales Market Share by Country (2020-2031)

Figure 44. Latin America Neurotherapy Revenue Market Share by Country (2020-2031)

Figure 45. Mexico Neurotherapy Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 46. Brazil Neurotherapy Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 47. Argentina Neurotherapy Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 48. Middle East and Africa Neurotherapy Sales Market Share by Country (2020-2031)

Figure 49. Middle East and Africa Neurotherapy Revenue Market Share by Country (2020-2031)

Figure 50. Turkey Neurotherapy Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 51. Saudi Arabia Neurotherapy Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 52. UAE Neurotherapy Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 53. Global Sales Market Share of Neurotherapy by Type (2020-2031)

Figure 54. Global Revenue Market Share of Neurotherapy by Type (2020-2031)

Figure 55. Global Neurotherapy Price (US$/Unit) by Type (2020-2031)

Figure 56. Global Sales Market Share of Neurotherapy by Application (2020-2031)

Figure 57. Global Revenue Market Share of Neurotherapy by Application (2020-2031)

Figure 58. Global Neurotherapy Price (US$/Unit) by Application (2020-2031)

Figure 59. Neurotherapy Value Chain

Figure 60. Channels of Distribution (Direct Vs Distribution)

Figure 61. Bottom-up and Top-down Approaches for This Report

Figure 62. Data Triangulation

Figure 63. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic

$2900

Single User License

Multi User

Electronic

$4350

Multi User License

Enterprise License

Electronic

$5800

Enterprise License

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions